Research project
Dr S Wilson: 'A randomised multi-centre, double-blind, placebo-controlled, parallel-group trial to explore the effects of omalizumab on airway inflammation and severe IgE-medicated asthma'
-
Research funder:Novartis Pharma AG
-
Status:Not active